Yingxiao Wu

Publications

Zhang, Z., Wu, Y., Roelle, S., Cheng, C., Schiemann, W., & Lu, Z. (2017). Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer.. Nature communications, 8 (1), 692.
Ye, Z., Zhou, Z., Ayat, N., Wu, Y., Jin, Y., Joshi-Imre, A., & Lu, Z. (2016). A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.. Contrast media & molecular imaging, 11 (1), 32-40.
Zhang, Z., Zhou, Z., Joshi-Imre, A., Wang, J., Wu, Y., Sun, D., Chen, Q., Zhu, H., Magi-Galluzzi, C., & Lu, Z. (2015). EDB Fibronectin Specific Peptide for Prostate Cancer Targeting.. Bioconjugate chemistry, 26 (5), 830-8.
Wu, Y., Xu, W., Liu, J., Huang, M., Luan, S., & Lee, Y. (2015). An Energy-Efficient Adaptive Sensing Framework for Gait Monitoring Using Smart Insole. IEEE SENSORS JOURNAL, 15 (4), 2335-2343.
Wu, Y., Balu, N., Li , W., Chen, Q., Joshi-Imre, A., Kummitha, C., Yu, X., Yuan, C., & Lu, Z. (2013). Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate.. American journal of nuclear medicine and molecular imaging, 3 (5), 446-55.